These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 31083646)

  • 21. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
    BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
    Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
    Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
    Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
    Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
    Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
    Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
    Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
    Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.
    Ashktorab H; Daremipouran M; Goel A; Varma S; Leavitt R; Sun X; Brim H
    Epigenetics; 2014 Apr; 9(4):503-12. PubMed ID: 24441198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients.
    Li M; Sun X; Yao H; Chen W; Zhang F; Gao S; Zou X; Chen J; Qiu S; Wei H; Hu Z; Chen W
    Toxicol Appl Pharmacol; 2021 Sep; 427():115657. PubMed ID: 34332992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
    Wang Y; Liu D; Jin X; Song H; Lou G
    Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis.
    Tong Y; Sun J; Wong CF; Kang Q; Ru B; Wong CN; Chan AS; Leung SY; Zhang J
    Genome Biol; 2018 Jun; 19(1):73. PubMed ID: 29871649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
    Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
    Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
    Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
    J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
    Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
    J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.
    Simmer F; Brinkman AB; Assenov Y; Matarese F; Kaan A; Sabatino L; Villanueva A; Huertas D; Esteller M; Lengauer T; Bock C; Colantuoni V; Altucci L; Stunnenberg HG
    Epigenetics; 2012 Dec; 7(12):1355-67. PubMed ID: 23079744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
    Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
    Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.